| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
B Repression
Departments of Medical Nutrition (L.-G.B., A.P., I.R., S.O.) and Biosciences (J.L., K.D.-W.), Karolinska Institutet, Karolinska University Hospital Huddinge, Novum, SE-141 86 Huddinge, Sweden; and KaroBio AB (L.-G.B., S.N.), Novum, SE-141 57 Huddinge, Sweden
Address all correspondence and requests for reprints to: Professor Sam Okret, Department of Medical Nutrition, Karolinska Institutet, Karolinska University Hospital Huddinge, Novum, SE-141 86 Huddinge, Sweden. E-mail: Sam.Okret{at}mednut.ki.se.
Glucocorticoid hormones (GCs) exert an antiproliferative effect on most cells. However, the molecular mechanism is still largely unclear. We investigated the antiproliferative mechanism by GCs in human embryonic kidney 293 cells with stably introduced glucocorticoid receptor (GR) mutants that discriminate between cross-talk with nuclear factor-
B (NF-
B) and activator protein-1 signaling, transactivation and transrepression, and antiproliferative vs. non-antiproliferative responses. Using the GR mutants, we here demonstrate a correlation between repression of NF-
B signaling and antiproliferative response. Gene expression profiling of endogenous genes in cells containing mutant GRs identified a limited number of genes that correlated with the antiproliferative response. This included a GC-mediated up-regulation of the NF-
B-inhibitory protein I
B
, in line with repression of NF-
B signaling being important in the GC-mediated antiproliferative response. Interestingly, the GC-stimulated expression of I
B
was a direct effect despite the inability of the GR mutant to transactivate through a GC-responsive element. Selective expression of I
B
in human embryonic kidney 293 cells resulted in a decreased percentage of cells in the S/G2/M phase and impaired cell proliferation. These results demonstrate that GC-mediated inhibition of NF-
B is an important mechanism in the antiproliferative response to GCs.
NURSA Molecule Pages Link:
This article has been cited by other articles:
![]() |
X. Wang, Y. Chen, Y. Wang, X. Zhu, Y. Ma, S. Zhang, and J. Lu Role of RHOB in the antiproliferative effect of glucocorticoid receptor on macrophage RAW264.7 cells J. Endocrinol., January 1, 2009; 200(1): 35 - 43. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sharma and A. Lichtenstein Dexamethasone-induced apoptotic mechanisms in myeloma cells investigated by analysis of mutant glucocorticoid receptors Blood, August 15, 2008; 112(4): 1338 - 1345. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Donet, P. Bosch, A. Sanchis, P. Bayo, A. Ramirez, J. L. Cascallana, A. Bravo, and P. Perez Transrepression Function of the Glucocorticoid Receptor Regulates Eyelid Development and Keratinocyte Proliferation but Is Not Sufficient to Prevent Skin Chronic Inflammation Mol. Endocrinol., April 1, 2008; 22(4): 799 - 812. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Mao, A. K. Stewart, R. Hurren, A. Datti, X. Zhu, Y. Zhu, C. Shi, K. Lee, R. Tiedemann, Y. Eberhard, et al. A chemical biology screen identifies glucocorticoids that regulate c-maf expression by increasing its proteasomal degradation through up-regulation of ubiquitin Blood, December 1, 2007; 110(12): 4047 - 4054. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Y. Zhang and R. A. Daynes Glucocorticoid Conditioning of Myeloid Progenitors Enhances TLR4 Signaling via Negative Regulation of the Phosphatidylinositol 3-Kinase-Akt Pathway J. Immunol., February 15, 2007; 178(4): 2517 - 2526. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. C. Jordan Medroxyprogesterone Acetate and Metastases: Of Mice and (wo)Men J Natl Cancer Inst, May 4, 2005; 97(9): 619 - 621. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |